Cervicomedullary hemangioblastoma treated with bevacizumab
Neurooncol Adv
.
2020 Sep 3;2(1):vdaa076.
doi: 10.1093/noajnl/vdaa076.
eCollection 2020 Jan-Dec.
Authors
Gloria Mak
1
,
Almunder Algird
2
,
Jeffrey Greenspoon
3
,
John Provias
4
,
Hal Hirte
3
Affiliations
1
Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
2
Department of Surgery, McMaster University, Hamilton, Ontario, Canada.
3
Department of Oncology, McMaster University, Hamilton, Ontario, Canada.
4
Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada.
PMID:
32908970
PMCID:
PMC7470470
DOI:
10.1093/noajnl/vdaa076
No abstract available
Keywords:
bevacizumab; hemangioblastoma.